Clearance Summary
Cefaly Dual Enhanced with RFID - OTC, Cefaly Dual Enhanced with RFID - Rx, Cefaly Dual Connected - OTC, Cefaly Dual Connected - Rx received FDA 510(k) clearance under submission number K212071, sponsored by Cefaly Technology. The device was reviewed via the Traditional premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2022-12-13.
- Submission: K212071
- Applicant / Sponsor: Cefaly Technology
- Clearance pathway: Traditional
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.5891
- Decision date: 2022-12-13
Classification & Regulation
This clearance is catalogued under FDA product code PCC and 21 CFR 882.5891, within the Neurology review panel as a Class II device.